The Antinociceptive Effects of Anticonvulsants in a Mouse Visceral Pain Model
- 1 June 2008
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Anesthesia & Analgesia
- Vol. 106 (6), 1897-1903
- https://doi.org/10.1213/ane.0b013e318172b993
Abstract
There is evidence supporting the antinociceptive effects of carbamazepine, oxcarbazepine, gabapentin, and topiramate in various models of neuropathic pain as well as inflammatory somatic pain. Data are lacking on the antinociceptive potential of these drugs against visceral pain. In this study, we examined and compared the effects of carbamazepine, oxcarbazepine, gabapentin, and topiramate in the writhing test as a visceral pain model in the mouse. In addition, the influence of these anticonvulsants on motor performance was examined to compare the tolerability of these anticonvulsants when used against acute visceral pain. The antinociceptive effects of these anticonvulsants were examined in the acetic acid writhing test in mice. The side effect propensity of these drugs was examined using the rotarod test. Carbamazepine (25-60 mg/kg; p.o.), oxcarbazepine (10-40 mg/kg; p.o.), gabapentin (10-70 mg/kg; p.o.), and topiramate (5-30 mg/kg; p.o.) caused a significant dose-dependent reduction the number of writhes in the writhing test. In the rotarod test, carbamazepine (60-140 mg/kg; p.o.) and oxcarbazepine (120-450 mg/kg; p.o.) significantly reduced the time spent on the rotarod in a dose- and time-dependent manner. Gabapentin (1000-2000 mg/kg; p.o.) and topiramate (400-1500 mg/kg; p.o.) did not produce significant impairment of motor performance at the highest doses used. The therapeutic index (motor impairing dose TD(50)/writhing ED(50)) values were topiramate (>148.5) > gabapentin (>60.2) > oxcarbazepine (15.2) > carbamazepine (2.3). These results indicate that oxcarbazepine, gabapentin, and topiramate are effective in the writhing model in mice, in a dose range, which is not related to motor impairment; topiramate is the most potent and the most tolerable drug.This publication has 27 references indexed in Scilit:
- The Additive Antinociceptive Interaction Between WIN 55,212-2, a Cannabinoid Agonist, and KetorolacAnesthesia & Analgesia, 2006
- The Suppressive Effects of Oxcarbazepine on Mechanical and Cold Allodynia in a Rat Model of Neuropathic PainAnesthesia & Analgesia, 2005
- Gabapentin for the prevention of postoperative pain after vaginal hysterectomyPain, 2004
- Isobolographic analysis of interaction between cyclooxygenase inhibitors and tramadol in acetic acid-induced writhing in miceProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2004
- Oxcarbazepine antinociception in animals with inflammatory pain or painful diabetic neuropathy.Clinical and Experimental Pharmacology and Physiology, 2004
- The Rationale and Use of Topiramate for Treating Neuropathic PainThe Clinical Journal of Pain, 2003
- Peripheral and preemptive opioid antinociception in a mouse visceral pain modelPain, 2001
- Visceral painThe Lancet, 1999
- Recent and forgotten aspects of visceral painEuropean Journal of Pain Supplements, 1999
- Effects of systemic carbamazepine and gabapentin on spinal neuronal responses in spinal nerve ligated ratsPain, 1998